First Opinion By Paul D. Thacker Don’t rewrite history: ‘Sunshine’ law was meant to protect docs from undue influence
Business By Rebecca Robbins Meet the furry pitchmen promoting a new drug for dogs scared of fireworks
Exclusive By Rebecca Robbins Drug makers now spend $5 billion a year on advertising. Here’s what that buys.
Business By Rebecca Robbins Inside the $100 million ad blitz for a $1,100-a-pill drug for hepatitis C
Exclusive By Sheila Kaplan Doctors promoting treatments on social media routinely fail to disclose ties to drug makers
Exclusive By Sheila Kaplan Here’s how doctors tweet medical advice — and what they’re not telling you
Business By Rebecca Robbins How much is an extra month of life worth? Drug makers face pressure to calculate
Health By Rebecca Robbins In the shadow of an opioid crisis, Super Bowl ad spotlights chronic pain patients